Month: May 2015

Anti-VEGF Therapy to Limit DR Progression

[ad_1] Dr. Ciulla recently authored a review on a new indication for Lucentis and Eylea, which have been shown to slow the progression of diabetic retinopathy… Anti-VEGF Therapy to Limit DR Progression Although many questions remain, anti-VEGF therapies for diabetic retinopathy treatment will dramatically alter